This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
D

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Dean Fennell
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Dean Fennell
106 views
June 6, 2024

Chapters

MIST5 Trial Results & Conclusions

00:00

Study Design & Patient Characteristics

01:16

Efficacy, Safety & Correlative Research

04:35

Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

17:22

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO …

2024 ASCO® Annual Meeting Insights Hub

A. Chiang

406 views

·

4 months ago
40:00

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

ecancer

B. Gyawali

97 views

·

4 months ago
04:26

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consol…

ecancer

P. Iyengar

37 views

·

4 months ago
View All

Recommended

36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

810 views

·

4 months ago
15:09

World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Oncology Data Advisor

S. Kareff, B. Sandy, M. Vojnic

142 views

·

2 months ago
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

·

4 months ago
12:10

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advanc…

2024 ASCO® Annual Meeting Insights Hub

M. Marmarelis

247 views

·

5 months ago
04:35

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Total Health

J. Bauman

232 views

·

1 year ago
11:28

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Che…

2024 ASCO® Annual Meeting Insights Hub

S. Popat

81 views

·

5 months ago
15:37

What’s New in NSCLC & Mesothelioma Immunotherapy

ImmunoTherapy Bridge 2023

A. Morabito

115 views

·

10 months ago
10:31

Immunotherapy for Patients With Mesothelioma

MI&T Congressi

J. Aerts

59 views

·

4 months ago
07:20

ASCO® 2024 Review: Treatment Updates on Unresectable Malignant Pleur…

Nebraska Oncology Society

V. Lam

32 views

·

2 months ago
08:14

Updates in Malignant Pleural Mesothelioma

2023 Texas Lung Cancer Conference Coverage

M. Marmarelis

186 views

·

1 year ago
09:04

Discovering Research Advances in Mesothelioma

Oncology Data Advisor

S. Kareff, E. Rodriguez

16 views

·

6 months ago
22:02

Significant Advances in Mesothelioma

OncoAlert

G. Mountzios

123 views

·

1 year ago
07:11

ESMO 2023 Insights: "First Survival Data From the NIPU Trial - Evalu…

Insights from 2023 ESMO Annual Meeting

A. Helland

72 views

·

1 year ago
08:40

MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Advance…

Laura Ridolfi

67 views

·

9 months ago
09:57

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

ILCC 2022 Conference Coverage

P. Baas

250 views

·

2 years ago
05:39

ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"

GRACE

J. West, C. Lovly, A. Addeo

60 views

·

1 year ago
05:22

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

ecancer

S. Peters

363 views

·

3 years ago
04:33

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable Advanc…

ecancer

P. Bradbury

35 views

·

1 year ago
16:56

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

WCLC 2022 Conference Coverage

M. Jakopovic

36 views

·

2 years ago
09:56

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

2020 Virtual ESMO Review

M. Dietrich

616 views

·

4 years ago
AUTOPLAY